Edward is a partner at Sofinnova Partners focused on Digital Medicine investments. Previously, Edward was at M Ventures, the €1bn AUM corporate VC-arm of Merck KGaA, where he was responsible for health-tech investments. Edward led, among others, investments in Akili Interactive Labs (the first-ever FDA-approved prescription videogame); Wiliot (battery-free Bluetooth tags with infinite lifetime, enabling a true connected-everything), and Biolinq (wearable continuous biosensing platform). Prior to M Ventures, Edward was in the Life Sciences securities team at Kempen & Co, a pan-European merchant bank, covering listed small- and mid-cap Life Sciences equities. He started his career as an analyst in the biopharma investment team of M Ventures. Edward holds an MSc in Biopharmaceutical Sciences from Leiden University, the Netherlands, with a specialisation in pharmacology.